Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
VentX trans-activates p53 and p16ink4a to regulate cellular senescence.
Wu X
,
Gao H
,
Ke W
,
Hager M
,
Xiao S
,
Freeman MR
,
Zhu Z
.
???displayArticle.abstract???
Cell senescence is a process of irreversible arrest of cell proliferation and plays an important role in tumor suppression. Recent studies showed that Wnt inhibition is a trigger of cellular senescence. Using methods of reverse genetics, we recently identified VentX, a human homolog of the vertebrate Xenopus Vent family of homeobox genes, as a novel Wnt repressor and a putative tumor suppressor in lymphocytic leukemia. Here, we show that VentX is a direct transcriptional activator of p53-p21 and p16ink4a-Rb tumor suppression pathways. Ectopic expression of VentX in cancer cells caused an irreversible cell cycle arrest with a typical senescence-like phenotype. Conversely, inhibition of VentX expression by RNA interference ameliorated chemotherapeutic agent-induced senescence in lymphocytic leukemia cells. The results of our study further reveal the mechanisms underlying tumor suppression function of VentX and suggest a role of VentX as a potential target in cancer prevention and treatment.
Abbas,
p21 in cancer: intricate networks and multiple activities.
2009, Pubmed
Abbas,
p21 in cancer: intricate networks and multiple activities.
2009,
Pubmed
Agirre,
TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia.
2003,
Pubmed
Ahuja,
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.
2005,
Pubmed
Basso,
Reverse engineering of regulatory networks in human B cells.
2005,
Pubmed
Behrens,
Functional interaction of beta-catenin with the transcription factor LEF-1.
1996,
Pubmed
,
Xenbase
Bignell,
Signatures of mutation and selection in the cancer genome.
2010,
Pubmed
Campisi,
Cellular senescence: when bad things happen to good cells.
2007,
Pubmed
Chen,
Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
2006,
Pubmed
Choi,
A genomic analysis of adult T-cell leukemia.
2007,
Pubmed
Collado,
Cellular senescence in cancer and aging.
2007,
Pubmed
Di Micco,
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
2006,
Pubmed
Espada,
Wnt signalling and cancer stem cells.
2009,
Pubmed
Funayama,
Cellular senescence and chromatin structure.
2007,
Pubmed
Gao,
Xom interacts with and stimulates transcriptional activity of LEF1/TCFs: implications for ventral cell fate determination during vertebrate embryogenesis.
2007,
Pubmed
,
Xenbase
Gao,
VentX, a novel lymphoid-enhancing factor/T-cell factor-associated transcription repressor, is a putative tumor suppressor.
2010,
Pubmed
Goodwin,
Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
2000,
Pubmed
HAYFLICK,
The serial cultivation of human diploid cell strains.
1961,
Pubmed
Hara,
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence.
1996,
Pubmed
Hemann,
Oncogenes and senescence: breaking down in the fast lane.
2007,
Pubmed
Huber,
Nuclear localization of beta-catenin by interaction with transcription factor LEF-1.
1996,
Pubmed
,
Xenbase
Kahlem,
Cellular senescence in cancer treatment: friend or foe?
2004,
Pubmed
Knudsen,
Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.
1997,
Pubmed
Lin,
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.
1998,
Pubmed
Lu,
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
2004,
Pubmed
Luo,
Deacetylation of p53 modulates its effect on cell growth and apoptosis.
2000,
Pubmed
Moretti,
Molecular cloning of a human Vent-like homeobox gene.
2001,
Pubmed
,
Xenbase
Narita,
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.
2003,
Pubmed
Omura-Minamisawa,
Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
2000,
Pubmed
Polager,
p53 and E2f: partners in life and death.
2009,
Pubmed
Prieur,
Cellular senescence in vivo: a barrier to tumorigenesis.
2008,
Pubmed
Pui,
Acute lymphoblastic leukemia.
2004,
Pubmed
Raman,
Compromised HOXA5 function can limit p53 expression in human breast tumours.
2000,
Pubmed
Rawat,
The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia.
2010,
Pubmed
,
Xenbase
Reya,
Wnt signalling in stem cells and cancer.
2005,
Pubmed
Rochette,
SW480, a p53 double-mutant cell line retains proficiency for some p53 functions.
2005,
Pubmed
Roninson,
Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids.
2003,
Pubmed
Roninson,
Tumor cell senescence in cancer treatment.
2003,
Pubmed
Schmitt,
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
2002,
Pubmed
Scholzen,
The Ki-67 protein: from the known and the unknown.
2000,
Pubmed
Serrano,
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
1997,
Pubmed
Sherr,
The RB and p53 pathways in cancer.
2002,
Pubmed
Simon,
Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
2005,
Pubmed
Ye,
Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells.
2007,
Pubmed
Ysebaert,
Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.
2006,
Pubmed
Zhao,
Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.
2007,
Pubmed
te Poele,
DNA damage is able to induce senescence in tumor cells in vitro and in vivo.
2002,
Pubmed
